Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q1 FY27 Earnings Presentation
32 slides from Krishna Institute Of Medical Sciences's earnings presentation, Aug 3, 2026
Slide 1: Cover letter to stock exchanges: Investor Presentation
03rd August 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra - Ku
Slide 2: Investor Presentation
Investor Presentation August 03, 2026 Private & Confidential
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The
Slide 4: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 5: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 6: Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS
Dr. Bhaskara Rao Bollineni - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bhaskara Rao Bollineni {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio-Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Executive Director & CEO Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. Abhinay Bollineni completed MBBS f
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Executive Director & CEO Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela R
Slide 9: Shareholding Pattern - As on 30 June, 2026
Shareholding Pattern - As on 30 June, 2026 th Retail & Others, Retail Pre IPO, 9.1% Top Institutional Share Holders 6.5% Share Holder Share Holding % Promoters, 32.5% SBI MF 4.8% Axis MF 4.4% HDFC MF 4.0% FII, 17.4% Invesco MF 3.5% Kotak Fund 3.0% Amansa Holdings Private Limited 2.2% LILAC Investmen
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 11: Many Firsts...
Many Firsts... • First in Asia to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Larges
Slide 12: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI) Perf
Slide 13: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 39,308 7,584 30,670 7,590 25,143 .1% 6,200 .9% R : 28 26 G CA GR: 22,235 CA 5,766 16,711 5,217 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023 2024 2025 2026 2005 2010 2015 2020 2022** 2023 2024 2025 2026 No. of No. of No
Slide 14: KIMS Journey: From Regional Leader to National Healthcare Roadmap
KIMS Journey: From Regional Leader to National Healthcare Roadmap Overall Bed Capacity of 9600+ Beds Year Andhra Pradesh Telangana Maharashtra Kerala Karnataka Tamil Nadu 2000 Nellore - 250 2001 Rajahmundry - 195 2004 Secunderabad - 1000 2011 Srikakulam - 300 2014 Kondapur - 220 2017 Ongole - 350 20
Slide 15: KIMS Journey: Strategic Levers for Future Growth
KIMS Journey: Strategic Levers for Future Growth Consistent Growth over 2 decades Achieved 26%+ CAGR in Revenue and 28%+ CAGR in EBITDA, reflecting sustained operational excellence and strategic expansion. Delivering high-quality care through affordable healthcare models, advanced These transplant p
Slide 16: Q1 FY27 Updates
Q1 FY27 Updates 15 Private & Confidential
Slide 17: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Millions) Financial Highlights Particulars Q1 FY27 Q4 FY26 Q1 FY26 QoQ (%) YoY (%) FY26 FY25 YoY (%) Operating Revenue 11,795 10,746 8,716 9.8% 35.3% 39,046 30,351 28.6% Other Income 164 97 71 69.1% 131.0% 262 319 -17.9% Total Revenue 11,959 10,843
Slide 18: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 Operational Highlights Particulars Q1 FY27 Q4 FY26 Q1 FY26 QoQ (%) YoY (%) IP Volume 72,493 63,595 57,275 14.0% 26.6% OP Volume 6,58,617 6,09,724 5,12,399 8.0% 28.5% ARPOB (Rs) 47,200 47,132 43,011 0.1% 9.7% ARPP (Rs) 1,63,573 1,69,983 1,53,094 (3.8%) 6.8% 17
Slide 19: Group Operating Performance
Group Operating Performance IP VOLUME (‘000) OP VOLUME (‘000) 15.4% 14.0% 25.4% 8.0% 246 72 2,300 659 64 610 213 57 1,834 512 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 OCCUPIED BEDS / OCCUPANCY %* ARPOB (‘000) 14.0% 0.1% 2,450 2,761 44.6 47.2 39.2 47.1 2,248 2,548 43.0 2,25
Slide 20: Group Operating and Financial Performance
Group Operating and Financial Performance Particulars FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 Bed Capacity# 5,179 6,464 7,459 6,464 5,499 Operational Beds 4,492 4,852 5,639 4,852 4,387 Census Beds 3,924 3,981 4,549 3,981 3,809 Non Census Beds 568 871 1,090 871 578 Occupied Beds 2,248 2,450 2,761 2,548 2
Slide 21: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA 10.3% 10.9% 28.2% 1.6% 39,308 11,959 8,282 2,398 10,843 8,148 2,162 8,787 1,997 30,670 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 FY25 FY26 Q1 FY26 Q4 FY26 Q1 FY27 PBT* PAT* (40.2%) (41.7%) 5,581 1,137 4,148 850 13.0% 3.3% 374 566 331 2,42
Slide 22: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Particulars FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 Bed Capacity# 1,797 1,882 2,669 1,882 1,817 2,214 2,314 2,314 2,314 2,214 Operational Beds 1,682 1,694 2,144 1,694 1,702 1,806 1,840 1,909 1,840 1,
Slide 23: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Maharashtra Kerala Karnataka Group Particulars FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 FY 26 Q1 FY27 Q4 FY26 FY 25 FY 26 Q1 FY27 Q4 FY26 Q1 FY26 Bed Capacity# 659 959 959 959 959 509 509 717 509 509 800 800 800 5,179 6,464 7
Slide 24: Ramp-up of Kerala Units
Ramp-up of Kerala Units (Rupees in Millions) Kannur EBITDA Positive Kollam EBITDA Positive Palakkad EBITDA Positive 353.6 219.3 203.1 322.0 253.6 170.5 87.3 84.3 12.4 52.7 14.8 14.8 7.0 (35.9) Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY27 NABH - Entry level NABH - In Pipeline NABH - Accredited •
Slide 25: Ramp-up of Maharashtra Units
Ramp-up of Maharashtra Units (Rupees in Millions) Nashik EBITDA Positive Thane 248.8 482.0 218.0 152.5 463.7 55.8 10.8 (97.9) (14.6) (92.3) (70.9) (79.9) Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 NABH - Entry level NABH - Accredited • Strengthening Access & Institutional Reach • Transplant Program E
Slide 26: Ramp-up of AP & Karnataka Units
Ramp-up of AP & Karnataka Units (Rupees in Millions) Vizag QNRI EBITDA Positive Mahadevapura (Bengaluru) Electronic City (Bengaluru) 398.8 550.6 259.0 360.4 214.0 164.0 63.2 485.7 25.5 (0.3) (146.2) (15.8) (252.0) (176.6) Q1FY26 Q4FY26 Q1FY27 Q4FY26 Q1FY27 Q4FY26 Q1FY27 NABH - Accredited NABH - Accr
Slide 27: Ramp-up of O&M Units
Ramp-up of O&M Units (Rupees in Millions) Sangli EBITDA Positive Guntur EBITDA Positive Kompally 277.4 317.9 121.4 243.6 272.3 235.3 195.0 22.6 14.8 13.5 18.7 (22.5) (1.8) (92.1) Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY27 NABH - Entry level NABH - Entry Level NABH - In Pipeline • Deeper Market
Slide 28: Revenue Mix & Cluster Profile (Group Q1FY27)
Revenue Mix & Cluster Profile (Group Q1FY27) SPECIALITY MIX PAYOR MIX CLUSTER TOTAL REVENUE Kerala 6.5% Karnataka Maharashtra Aarogyasri 6.8% 12.6% 4% Others Cardiac Sciences 22% 15% Andhra Pradesh Corporate Cash 21.9 12% 52% Telangana 52.2% Renal Sciences 9% Mother & Child 9% Organ Oncology Transpl
Slide 29: Key Achievements in Q1 FY27
Key Achievements in Q1 FY27 28 Private & Confidential
Slide 30: Key Achievements in Q1 FY27
Key Achievements in Q1 FY27 29 Private & Confidential
Slide 31: Corporate Structure (As on 30 June 2026)
Corporate Structure (As on 30 June 2026) th Krishna Institute of Medical Sciences Limited Units Wholly Owned Subsidiaries KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Thane KIMS QNRI KIMS Swastha KHPL (100%) (100%) (100%) (100%) (100%) Visakhapatnam Kerala Rajahmundry (100%) (100
Slide 32: Thank You
Thank You 31 Private & Confidential
Krishna Institute of Medical Sciences — Q1 FY27 Earnings Presentation on 6ix